Melatonin Use Helped Stabilize Rare Insulinoma Case
A patient with a rare pancreatic tumor saw fewer blood sugar crashes while taking melatonin.
Updated on Sept. 29, 2026 in Diabetes
Live Poll
Would you use an over-the-counter supplement to manage unexplained health symptoms without seeing a doctor?
In an April 2026 case report, researchers documented a 64-year-old patient whose life-threatening hypoglycemia, caused by a rare pancreatic tumor, improved after nightly melatonin use. This observational finding highlights a potential, yet still poorly understood, interaction between melatonin receptors and insulin-secreting tumors.
Why it matters
Insulinoma is an extremely rare condition, and these findings offer a potential mechanism involving melatonin receptors to explore for future treatments. However, because melatonin can impact glucose metabolism differently in various populations, this does not serve as a clinical recommendation.
A published case report analyzed a 64-year-old patient whose time spent with dangerously low blood sugar dropped from 19% to 1% after taking 10 mg of melatonin nightly for four months. Researchers identified the presence of melatonin receptors on the patient's pancreatic tumor through tissue staining.
The players
Mayo Clinic
A medical research organization that participated in the study of this case.
University of British Columbia
A public research university whose researchers contributed to the case study.
The details
Researchers hypothesize that the 10 mg nightly dose of melatonin acted on receptors identified on the surface of the patient's 11-millimeter pancreatic neuroendocrine tumor. By binding to these receptors, the melatonin potentially inhibited the tumor from releasing excessive amounts of insulin into the bloodstream. This inhibition reduced the frequency of hypoglycemic episodes, where the patient's blood sugar had dropped as low as 22 mg/dL.
Timeline
April 2026: Case report published in JCEM Case Reports.
June 2026: Trial published in Diabetes Care regarding melatonin and glucose.
September 29, 2026: Article publication date.
Health Landscape
This case adds a unique observation to the broader field of endocrine research regarding how hormonal signals like melatonin interact with insulin-producing tissues. It follows a path of investigation that seeks to understand the diverse ways tumors can be regulated by external pharmacological agents.
This finding is specific to a very rare tumor and does not suggest that melatonin should be used to manage general blood sugar issues. If you experience unexplained blood sugar fluctuations, it is essential to discuss these symptoms with your physician for proper diagnostic testing.
The takeaway
While this case shows a unique interaction between melatonin and a specific type of pancreatic tumor, it should not be viewed as a general treatment for blood sugar management. Always consult with your doctor before starting any new supplement to ensure it is appropriate for your health history.
Further reading
For more information on the management of glucose-related health conditions, visit our section on Diabetes.
Source note: This article includes information reported by Medical Daily.
Live Poll
Would you use an over-the-counter supplement to manage unexplained health symptoms without seeing a doctor?
